Semin Thromb Hemost 2019; 45(01): 113-114
DOI: 10.1055/s-0038-1657780
Letter to the Editor
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Comment on “Venous and Arterial Thromboses: Two Sides of the Same Coin?”

Silvia Hoirisch-Clapauch
1  Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil
› Author Affiliations
Funding No funding was provided for this article.
Further Information

Address for correspondence

Silvia Hoirisch-Clapauch, MD, PhD
Av. Atlantica 434–1101, CEP 22010-000, Rio de Janeiro
Brazil   

Publication History

Publication Date:
18 June 2018 (eFirst)

 

I read with interest Lippi and Favaloro's paper discussing aspects of venous and arterial thromboses.[1] I wonder whether anxiety-related hyperfibrinolysis and depression-related hypofibrinolysis could explain the difference between white and red arterial thrombi.

White thrombi, for example, are seen in about three-quarters of the patients with unstable angina, but not in patients with myocardial infarction.[2] Unstable angina is associated with the rupture of the fibrous cap covering the atherosclerotic plaque, which often results from physical stress or anxiety, a physiological response to emotional stress.[3] Three important processes related to stress-induced catecholamine release contribute to thrombi formation: vasoconstriction, coagulation abnormalities, and, paradoxical as it may seem, hyperfibrinolysis. Vasoconstriction not only favors plaque rupture by increasing shear forces on atherosclerotic plaques but also shifts fluid from the intravascular to the extravascular compartment, thus increasing viscosity. The coagulation abnormalities accompanying anxiety include increased levels of factor VIII, fibrinogen, and von Willebrand factor.[4] Anxiety is also characterized by increased platelet aggregability,[5] which accounts for the high platelet content of the white thrombus, and by acute release of tissue plasminogen activator (tPA) into the circulation.[6] Resultant hyperfibrinolysis may render plaques vulnerable to rupture because matrix metalloproteinases (MMPs) such as MMP9 are activated by plasmin. MMP9, highly expressed in unstable coronary atherosclerotic plaques,[7] degrades the extracellular matrix, weakening the plaque's fibrous cap[3] and exposing plaque lipids and the subendothelial matrix to circulating blood.

Red thrombi are seen in all patients with myocardial infarction, but only in a minority of patients with unstable angina. These thrombi are usually formed in mildly or severely stenotic vessels, with superficial erosion or even without plaque rupture. While increased fibrinolytic activity seems to have a leading role in the pathogenesis of unstable angina, low fibrinolytic activity seems to be the common denominator to a variety of risk factors for myocardial infarction. For example, both cigarette smoking and inhalation of particulate air pollution impair endothelial release of tPA.[8] [9] [10] In obesity, periodontal disorder, and other inflammatory conditions, high levels of tumor necrosis factor-α stimulate plasminogen activator inhibitor (PAI)-1 synthesis.[8] [11] Hyperhomocysteinemia, another risk factor for myocardial infarction, impairs tPA binding to its receptor, annexin A2, therefore inhibiting tPA activation of plasmin.[8] [12]

Two studies reinforce the hypothesis that comorbid anxiety and depression, not just anxiety, increases the risk of myocardial infarction. In one of these, the number of admissions related to myocardial infarction did not increase when the UK team played in the 2002 World Cup, the exception being when the United Kingdom lost to Argentina in a penalty shoot-out.[13] A French study demonstrated that mortality related to myocardial infarction reduced when the French team won the World Cup in 1998.[14]

The links between depression and hypofibrinolysis include a high prevalence of cigarette smoking impairing endothelial release of tPA, and increased levels of PAI-1, due to different mechanisms.[12] [15] [16] Depressive disorders, in general, are associated with increased levels of tumor necrosis factor-α. In its turn, melancholic depression is accompanied by hypercortisolism, while atypical depression is accompanied by postprandial hyperinsulinemia. All three, tumor necrosis factor-α, cortisol, and insulin, stimulate PAI-1 gene expression.[11]

Importantly, men tend to deny depression.[17] For patients at risk for myocardial infarction, it is suggested that antidepressants should be prescribed not to treat depression but to restore fibrinolytic activity.


#

Conflict of Interest

The author reports no conflict of interest.


Address for correspondence

Silvia Hoirisch-Clapauch, MD, PhD
Av. Atlantica 434–1101, CEP 22010-000, Rio de Janeiro
Brazil